Drug use in business bathrooms: An exploratory study of manager encounters in New York City

International Journal of Drug Policy

Volumn 39, Issue , 2017, Pages 69-77

  Wolfson Stofko, Brett ^a,c   Bennett, Alex S ^a,c   Elliott, Luther ^a,c   Curtis, Ric ^b,c  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Harm reduction; Naloxone; Overdose; People who inject drugs; Public injection; Risk environment

Indexed keywords

COCAINE; NALOXONE;

ARTICLE; BATH; COMMERCIAL PHENOMENA; DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; EXPLORATORY RESEARCH; HEALTH EDUCATION; HUMAN; INTRAVENOUS DRUG ABUSE; MANAGER; MORTALITY RATE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; WORK EXPERIENCE; NEW YORK; OPIATE ADDICTION; SANITATION; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE;

COMMERCE; DRUG OVERDOSE; HUMANS; NEW YORK CITY; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE, INTRAVENOUS; TOILET FACILITIES;

EID: 84992061370     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.08.014     Document Type: Article

References (91)

1. Andresen, M.A., Boyd, N., A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. International Journal of Drug Policy 21:1 (2010), 70–76, 10.1016/j.drugpo.2009.03.004.
2. Beletsky, L., Davis, C.S., Anderson, E., Burris, S., The law (and politics) of safe injection facilities in the United States. American Journal of Public Health 98:2 (2008), 231–237, 10.2105/AJPH.2006.103747.
3. Blenkharn, J.I., Clinical wastes in the community: Local authority management of discarded drug litter. Public Health 122:7 (2008), 725–728, 10.1016/j.puhe.2007.09.013.
4. Bourgois, P., In search of respect: Selling crack in El Barrio. 1995, Cambridge University Press.
5. Bourgois, P., The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse 33:11 (1998), 2323–2351, 10.3109/10826089809056260.
6. Centers for Disease Control and Prevention, CDC WONDER. 2015 Retrieved from http://wonder.cdc.gov.
7. Cerdá, M., Ransome, Y., Keyes, K.M., Koenen, K.C., Tardiff, K., Vlahov, D., Galea, S., et al. Revisiting the role of the urban environment in substance use: The case of analgesic overdose fatalities. American Journal of Public Health 103:12 (2013), 2252–2260, 10.2105/AJPH.2013.301347.
8. Cicero, T.J., Ellis, M.S., Surratt, H.L., Kurtz, S.P., The changing face of heroin use in the united states: A retrospective analysis of the past 50 years. JAMA Psychiatry 71:7 (2014), 821–826, 10.1001/jamapsychiatry.2014.366.
9. Cooper, H., Moore, L., Gruskin, S., Krieger, N., The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Social Science & Medicine 61:3 (2005), 673–684.
10. Crabtree, A., Mercer, G., Horan, R., Grant, S., Tan, T., Buxton, J.A., A qualitative study of the perceived effects of blue lights in washrooms on people who use injection drugs. Harm Reduction Journal, 10, 2013, 10.1186/1477-7517-10-22 22–22.
11. DeBeck, K., Small, W., Wood, E., Li, K., Montaner, J., Kerr, T., Public injecting among a cohort of injecting drug users in Vancouver, Canada. Journal of Epidemiology and Community Health 63:1 (2009), 81–86, 10.1136/jech.2007.069013.
12. DeBeck, K., Kerr, T., Bird, L., Zhang, R., Marsh, D., Tyndall, M., Wood, E., Injection drug use cessation and use of North America's first medically supervised safer injecting facility. Drug and Alcohol Dependence 113:2–3 (2011), 172–176, 10.1016/j.drugalcdep.2010.07.023.
13. Dovey, K., Fitzgerald, J., Choi, Y., Safety becomes danger: Dilemmas of drug-use in public space. Health & Place 7:4 (2001), 319–331, 10.1016/S1353-8292(01)00024-7.
14. Dunlap, E., Johnson, B.D., Kotarba, J.A., Fackler, J.L., Macro-level social forces and micro-level consequences: Poverty, alternate occupations, and drug dealing. Journal of Ethnicity in Substance Abuse 9:2 (2010), 115–127, 10.1080/15332641003772611.
15. Freeman, K., Jones, C.G.A., Weatherburn, D.J., Rutter, S., Spooner, C.J., Donnelly, N., The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug and Alcohol Review 24:2 (2005), 173–184, 10.1080/09595230500167460.
16. Galea, S., Ahern, J., Vlahov, D., Coffin, P.O., Fuller, C., Leon, A.C., Tardiff, K., Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug and Alcohol Dependence 70:2 (2003), 139–148, 10.1016/S0376-8716(02)00342-3.
17. Gibson, E.K., Exner, H., Stone, R., Lindquist, J., Cowen, L., Roth, E.A., A mixed methods approach to delineating and understanding injection practices among clientele of a Victoria, British Columbia needle exchange program. Drug and Alcohol Review 30:4 (2011), 360–365, 10.1111/j. 1465-3362.2010.00219.x.
18. Gotsens, M., Marí-Dell'Olmo, M., Martínez-Beneito, M.Á., Pérez, K., Pasarín, M.I., Daponte, A., Borrell, C., Socio-economic inequalities in mortality due to injuries in small areas of ten cities in Spain (MEDEA Project). Accident Analysis & Prevention 43:5 (2011), 1802–1810, 10.1016/j.aap.2011.04.013.
19. Green, T.C., Heimer, R., Grau, L.E., Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction (Abingdon, England) 103:6 (2008), 979–989, 10.1111/j. 1360-0443.2008.02182.x.
20. Hannon, L., Cuddy, M.M., Neighborhood ecology and drug dependence mortality: An analysis of New York City census tracts. The American Journal of Drug and Alcohol Abuse 32:3 (2006), 453–463, 10.1080/00952990600753966.
21. Harm Reduction Coalition (2012). Guide to developing and managing overdose prevention and take-home naloxone projects. Retrieved from.
22. Hart Research Associates, Key findings from a survey on fast food worker safety., 2015 Retrieved from National Council for Occupational Safety and Health http://www.coshnetwork.org/national-cosh-reports.
23. Hunt, N., Lloyd, C., Kimber, J., Tompkins, C., Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. International Journal of Drug Policy 18:1 (2007), 62–65, 10.1016/j.drugpo.2006.11.018.
24. Injection Drug Users Health Alliance (2015). Injection drug users health alliance (IDUHA): Citywide evaluation study. Retrieved from.
25. Jones, C.M., Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002–2004 and 2008–2010. Drug and Alcohol Dependence 132:1–2 (2013), 95–100, 10.1016/j.drugalcdep.2013.01.007.
26. Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., Wood, E., Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence 87:1 (2007), 39–45, 10.1016/j.drugalcdep.2006.07.009.
27. Kerr, T., Kimber, J., DeBeck, K., Wood, E., The role of safer injection facilities in the response to HIV/AIDS among injection drug users. Current HIV/AIDS Reports 4:4 (2007), 158–164, 10.1007/s11904-007-0023-8.
28. Kerr, T., Stoltz, J.-A., Tyndall, M., Li, K., Zhang, R., Montaner, J., Wood, E., Impact of a medically supervised safer injection facility on community drug use patterns: A before and after study. BMJ: British Medical Journal 332:7535 (2006), 220–222.
29. Kerr, T., Tyndall, M., Li, K., Montaner, J., Wood, E., Safer injection facility use and syringe sharing in injection drug users. The Lancet 366:9482 (2005), 316–318, 10.1016/S0140-6736(05)66475-6.
30. Kerr, T., Tyndall, M.W., Zhang, R., Lai, C., Montaner, J.S.G., Wood, E., Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. American Journal of Public Health 97:7 (2007), 1228–1230, 10.2105/AJPH.2006.086256.
31. Kinner, S.A., Milloy, M.J., Wood, E., Qi, J., Zhang, R., Kerr, T., Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addictive Behaviors 37:6 (2012), 691–696, 10.1016/j.addbeh.2012.01.019.
32. Koester, S., Glanz, J., Barón, A., Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention. AIDS and Behavior 9:1 (2005), 27–39, 10.1007/s10461-005-1679-y.
33. Latkin, C., Srikrishnan, A.K., Yang, C., Johnson, S., Solomon, S.S., Kumar, S., Solomon, S., The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug and Alcohol Dependence 110:3 (2010), 221–227, 10.1016/j.drugalcdep.2010.03.004.
34. Lawitts, S., Needle sightings and on-the-job needle-stick injuries among New York City Department of Sanitation Workers. Journal of the American Pharmacists Association 42:6S (2002), S92–S93.
35. Leung, L.T.F., Ti, L., Hayashi, K., Suwannawong, P., Kaplan, K., Wood, E., Kerr, T., Health and safety risks associated with public injecting among people who inject drugs in Bangkok, Thailand. Drug and Alcohol Review 32:6 (2013), 582–587, 10.1111/dar.12060.
36. Linton, S.L., Celentano, D.D., Kirk, G.D., Mehta, S.H., The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug and Alcohol Dependence 132:3 (2013), 457–465, 10.1016/j.drugalcdep.2013.03.009.
37. Lorentz, J., Hill, L., Samimi, B., Occupational needlestick injuries in a metropolitan police force. American Journal of Preventive Medicine 18:2 (2000), 146–150, 10.1016/S0749-3797(99)00137-3.
38. Lowry, R., Concepts & applications of inferential statistics. 2015 Retrieved from http://vassarstats.net/textbook/index.html.
39. Mars, S.G., Bourgois, P., Karandinos, G., Montero, F., Ciccarone, D., Every ‘Never’ I ever said came true: Transitions from opioid pills to heroin injecting. International Journal of Drug Policy 25:2 (2014), 257–266, 10.1016/j.drugpo.2013.10.004.
40. Marshall, B.D.L., Kerr, T., Qi, J., Montaner, J.S.G., Wood, E., Public injecting and HIV risk behaviour among street-involved youth. Drug and Alcohol Dependence 110:3 (2010), 254–258, 10.1016/j.drugalcdep.2010.01.022.
41. Marshall, B.D.L., Milloy, M.J., Wood, E., Montaner, J.S.G., Kerr, T., Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet 377:9775 (2011), 1429–1437, 10.1016/S0140-6736(10)62353-7.
42. Marzuk, P.M., Tardiff, K., Leon, A.C., Hirsch, C.S., Stajic, M., Portera, L., Hartwell, N., Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: An ecological study. The American Journal of Drug and Alcohol Abuse 23:2 (1997), 221–228, 10.3109/00952999709040943.
43. Mateu-Gelabert, P., Guarino, H., Jessell, L., Teper, A., Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. Journal of Substance Abuse Treatment 48:1 (2015), 13–20, 10.1016/j.jsat.2014.07.002.
44. McKnight, I., Maas, B., Wood, E., Tyndall, M.W., Small, W., Lai, C., Kerr, T., Factors associated with public injecting among users of Vancouver's supervised injection facility. The American Journal of Drug and Alcohol Abuse 33:2 (2007), 319–325, 10.1080/00952990601175102.
45. Milloy, M.J., Kerr, T., Mathias, R., Zhang, R., Montaner, J.S., Tyndall, M., Wood, E., Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse 34:4 (2008), 499–509, 10.1080/00952990802122457.
46. New York City Department of Health and Mental Hygiene (2006). New York City: United Hospital Fund (UHF) Neighborhoods and NYC Zip Code Areas. nyc.gov.
47. New York City Department of Health and Mental Hygiene (2010). HIV Risk and Prevalence among New York City Injection Drug Users: 2009 National HIV Behavioral Surveillance Study. Retrieved from.
48. New York City Department of Health and Mental Hygiene (2013). HIV risk and prevalence among New York City injection drug users: 2012 National HIV behavioral surveillance study. Retrieved from.
49. New York City Department of Health and Mental Hygiene (2015a). Article 81 of the NYC health code: Food Preparation and food establishments, §81.22b C.F.R.
50. New York City Department of Health and Mental Hygiene (2015b). Unintentional drug poisoning (overdose) deaths involving opioids in New York City, 2000–2014. Retrieved from New York, NY.
51. New York State Restaurant Association (2015). [Safe sharps disposal and needle stick injury reporting training requirements for restaurant managers].
52. Novak, S.P., Bluthenthal, R., Wenger, L., Chu, D., Kral, A.H., Initiation of heroin and prescription opioid pain relievers by birth cohort. American Journal of Public Health 106:2 (2015), 298–300, 10.2105/AJPH.2015.302972.
53. Otiashvili, D., Latypov, A., Kirtadze, I., Ibragimov, U., Zule, W., Drug preparation, injection, and sharing practices in Tajikistan: A qualitative study in Kulob and Khorog. Substance Abuse Treatment, Prevention, and Policy, 11, 2016, 21, 10.1186/s13011-016-0065-2.
54. Papenburg, J., Blais, D., Moore, D., Al-Hosni, M., Laferrière, C., Tapiero, B., Quach, C., Pediatric injuries from needles discarded in the community: Epidemiology and risk of seroconversion. Pediatrics 122:2 (2008), e487–e492, 10.1542/peds.2008-0290.
55. Parkin, S., Habitus and drug using environments: Health, place and lived-experience. 2013, Ashgate Publishing Ltd.
56. Parkin, S., An applied visual sociology: Picturing harm reduction. 2014, Ashgate Publications Ltd., Farngate.
57. Parkin, S., Colliding intervention in the spatial management of street-based injecting and drug-related litter within settings of public convenience (UK). Space and Polity 20:1 (2016), 75–94, 10.1080/13562576.2015.1077548.
58. Parkin, S., Coomber, R., Public injecting and symbolic violence. Addiction Research & Theory 17:4 (2009), 390–405, 10.1080/16066350802518247.
59. Parkin, S., Coomber, R., Fluorescent blue lights, injecting drug use and related health risk in public conveniences: Findings from a qualitative study of micro-injecting environments. Health & Place 16:4 (2010), 629–637, 10.1016/j.healthplace.2010.01.007.
60. Parkin, S., Coomber, R., Injecting drug user views (and experiences) of drug-related litter bins in public places: A comparative study of qualitative research findings obtained from UK settings. Health & Place 17:6 (2011), 1218–1227, 10.1016/j.healthplace.2011.08.002.
61. Parkin, S., Coomber, R., Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): A Lefebvrian analysis. Health & Place 17:3 (2011), 717–726, 10.1016/j.healthplace.2011.02.001.
62. Petrar, S., Kerr, T., Tyndall, M.W., Zhang, R., Montaner, J.S.G., Wood, E., Injection drug users’ perceptions regarding use of a medically supervised safer injecting facility. Addictive Behaviors 32:5 (2007), 1088–1093, 10.1016/j.addbeh.2006.07.013.
63. Prussing, C., Bornschlegel, K., Balter, S., Hepatitis C surveillance among youth and young adults in New York City, 2009–2013. Journal of Urban Health 92:2 (2015), 387–399, 10.1007/s11524-014-9920-5.
64. Rhodes, T., The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 13:2 (2002), 85–94, 10.1016/S0955-3959(02)00007-5.
65. Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., Holloway, G., Public injecting and the need for ‘safer environment interventions’ in the reduction of drug-related harm. Addiction 101:10 (2006), 1384–1393, 10.1111/j. 1360-0443.2006.01556.x.
66. Rhodes, T., Watts, L., Davies, S., Martin, A., Smith, J., Clark, D., Lyons, M., Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science & Medicine 65:3 (2007), 572–585.
67. Rivera, A.V., DeCuir, J., Crawford, N.D., Amesty, S., Lewis, C.F., Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010–2012. Drug and Alcohol Dependence 144 (2014), 259–264, 10.1016/j.drugalcdep.2014.09.778.
68. Ross, N.A., Wolfson, M.C., Dunn, J.R., Berthelot, J.-M., Kaplan, G.A., Lynch, J.W., Relation between income inequality and mortality in Canada and in the United States: Cross sectional assessment using census data and vital statistics. BMJ: British Medical Journal 320:7239 (2000), 898–902.
69. Russell, F.M., Nash, M.C., A prospective study of children with community-acquired needlestick injuries in Melbourne. Journal of Paediatrics and Child Health 38:3 (2002), 322–323, 10.1046/j. 1440-1754.2002. t01-2-00859.x.
70. Salmon, A.M., Thein, H.-H., Kimber, J., Kaldor, J.M., Maher, L., Five years on: What are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?. International Journal of Drug Policy 18:1 (2007), 46–53, 10.1016/j.drugpo.2006.11.010.
71. Salmon, A.M., Dwyer, R., Jauncey, M., van Beek, I., Topp, L., Maher, L., Injecting-related injury and disease among clients of a supervised injecting facility. Drug and Alcohol Dependence 101:1–2 (2009), 132–136, 10.1016/j.drugalcdep.2008.12.002.
72. Schoenbaum, E.E., Hartel, D., Selwyn, P.A., Klein, R.S., Davenny, K., Rogers, M., Friedland, G., Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine 321:13 (1989), 874–879, 10.1056/NEJM198909283211306.
73. Seelye, K.Q., Heroin epidemic increasingly seeps into public view. 2016, New York Times Retrieved from http://www.nytimes.com/2016/03/07/us/heroin-epidemic-increasingly-seeps-into-public-view.html?_r=0; March 6, 2016.
74. Small, W., Rhodes, T., Wood, E., Kerr, T., Public injection settings in Vancouver: Physical environment, social context and risk. International Journal of Drug Policy 18:1 (2007), 27–36, 10.1016/j.drugpo.2006.11.019.
75. Small, W., Van Borek, N., Fairbairn, N., Wood, E., Kerr, T., Access to health and social services for IDU: The impact of a medically supervised injection facility. Drug and Alcohol Review 28:4 (2009), 341–346, 10.1111/j.1465-3362.2009.00025.x.
76. Sohn, J.-W., Kim, B.-G., Kim, S.-H., Han, C., Mental health of healthcare workers who experience needlestick and sharps injuries. Journal of Occupational Health 48:6 (2006), 474–479, 10.1539/joh.48.474.
77. Stoltz, J.-A., Wood, E., Small, W., Li, K., Tyndall, M., Montaner, J., Kerr, T., Changes in injecting practices associated with the use of a medically supervised safer injection facility. Journal of Public Health 29:1 (2007), 35–39, 10.1093/pubmed/fdl090.
78. Strathdee, S.A., Shoptaw, S., Dyer, T.P., Quan, V.M., Aramrattana, A., The Substance Use Scientific Committee of the HIV Prevention Trials Network, Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention. Current Opinion in HIV and AIDS 7:4 (2012), 320–325, 10.1097/COH.0b013e32835369ad.
79. Substance Abuse and Mental Health Services Administration (SAMHSA), Results from the 2012 national survey on drug use and health: Summary of national findings. 2013 Retrieved from HHS.
80. Suen, L., Huang, H., Lee, H., A comparison of convenience sampling and purposive sampling. The Journal of Nursing 61:3 (2014), 105–111.
81. Sullivan, M., Getting paid: Youth crime and work in the inner city. 1989, Cornell University Press, Ithaca, NY.
82. Topp, L., Iversen, J., Conroy, A., Salmon, A.M., Maher, L., on behalf of the Collaboration of Australian NSPs, Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Australian and New Zealand Journal of Public Health 32:1 (2008), 34–37, 10.1111/j.1753-6405.2008.00163.x.
83. Tukey, J.W., Comparing individual means in the analysis of variance. Biometrics 5:2 (1949), 99–114, 10.2307/3001913.
84. United States Census Bureau, 2010–2014 American community survey 5-year estimates. 2016 Retrieved from factfinder.census.gov.
85. Weeks, M.R., Clair, S., Singer, M., Radda, K., Schensul, J.J., Wilson, D.S., Knight, G., High Risk drug use sites, meaning and practice: Implications for AIDS prevention. Journal of Drug Issues 31:3 (2001), 781–808, 10.1177/002204260103100314.
86. Wheeler, E., Jones, T., Gilbert, M., Davidson, P., Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. 2015 Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6423a2.htm.
87. Wood, E., Kerr, T., Small, W., Li, K., Marsh, D.C., Montaner, J.S.G., Tyndall, M.W., Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ: Canadian Medical Association Journal 171:7 (2004), 731–734, 10.1503/cmaj.1040774.
88. Wood, E., Tyndall, M.W., Lai, C., Montaner, J.S.G., Kerr, T., Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Substance Abuse Treatment, Prevention, and Policy, 1, 2006, 10.1186/1747-597X-1-13 13–13.
89. Wood, E., Tyndall, M.W., Zhang, R., Montaner, J.S.G., Kerr, T., Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 102:6 (2007), 916–919, 10.1111/j.1360-0443.2007.01818.x.
90. Wood, E., Tyndall, M.W., Zhang, R., Stoltz, J.-A., Lai, C., Montaner, J.S.G., Kerr, T., Attendance at supervised injecting facilities and use of detoxification services. New England Journal of Medicine 354:23 (2006), 2512–2514, 10.1056/NEJMc052939.
91. World Health Organization (Producer) (2015, November 26, 2015). Health care worker health and safety: Preventing needlestick injury and occupational exposure to bloodborne pathogens. protecting healthcare workers: Preventing needlestick injuries toolkit. [Powerpoint].